MENU
GNMSF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Genmab A/S (GNMSF) Ownership - Who owns Genmab A/S?
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
Profile
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.6B
P/E Ratio
11.07
Total Cash
21.1B
Projected Growth
1.07
Total Debt
1.03B
Revenue
21.53B
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash/Share
338.63
Total Debt/Equity
N/A
Revenue/Share
50.62 USD as % of share price
Fundamentals
GNMSF
Capitalization
12.6B
P/E Ratio
11.07
Risk (Beta)
0.60
Dividend Yield
N/A
Total Cash
21.1B
Total Cash/Share
338.63
Total Debt
1.03B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.07
Revenue/Share (as % of the share price)
50.62%
Revenue
21.5B
ROE
N/A
Book Value
36.7B
P/B Ratio
2.28
Cash Flow
N/A
Earnings
122.21
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66M
Current Ratio
5.25
Current Revenue Per Employee
2401566.00
Dividends Per Share - Security
N/A
EBITDA
9.7B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.77
Revenue To Assets
19.34
Shares Held By Institutions
15.4B
Shares Outstanding - Current
62.3M
Total Liabilities
9.11B
Total Volume MTD
N/A
Value
N/A
Gain YTD
-1.490
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com